Bottom line
FTDZX vs FBIOX: the short answer
FTDZX (Franklin Biotechnology Discovery Fund) and FBIOX (Biotechnology Portfolio) are both mutual funds.
FBIOX is cheaper at 0.62% vs 0.76% — a difference of $14 a year per $10,000 invested.
Over five years, FTDZX returned +6.4% a year vs +3.5% for FBIOX (reporting dates differ).
Updated Nov 19, 2026
FTDZX vs FBIOX side by side
| FTDZX | FBIOX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Franklin Templeton | Fidelity |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.76% | 0.62% |
| Annual cost per $10k | $76 | $62 |
| 10-yr cost on $10k (prospectus) | $954 | $774 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +52.7% | +36.4% |
| 5-yr return (annualized) | +6.4% | +3.5% |
| 10-yr return (annualized) | +7.2% | +6.9% |
| Best quarter | — | +33.6% |
| Worst quarter | — | −28.4% |
| Net assets (fund) | $1.2B | $5.3B |
| Number of holdings | 126 | 215 |
| Portfolio turnover | 38% | 45% |
| Returns as of | Dec 31, 2025 | Apr 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of FTDZX's top 25 holdings also appear in FBIOX's top 25.
| Holding | FTDZX | FBIOX |
|---|---|---|
| Jazz Pharmaceuticals plc | 5.66% | 1.84% |
| Amgen, Inc. | 4.39% | 6.53% |
| Gilead Sciences, Inc. | 3.86% | 4.82% |
| Argenx SE | 3.62% | 2.25% |
| Revolution Medicines, Inc. | 3.01% | 2.02% |
| Ascendis Pharma A/S | 2.56% | 2.04% |
| Insmed, Inc. | 1.99% | 2.25% |
| Praxis Precision Medicines, Inc. | 1.91% | 2.47% |
| Bridgebio Pharma, Inc. | 1.67% | 0.89% |
| Tango Therapeutics, Inc. | 1.23% | 0.98% |
Source: SEC Form N-PORT
FTDZX top 10
- Jazz Pharmaceuticals plc — 5.66%
- Amgen, Inc. — 4.39%
- Gilead Sciences, Inc. — 3.86%
- Regeneron Pharmaceuticals, Inc. — 3.77%
- Argenx SE — 3.62%
- Vertex Pharmaceuticals, Inc. — 3.54%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Revolution Medicines, Inc. — 3.01%
- Guardant Health, Inc. — 2.76%
- Ascendis Pharma A/S — 2.56%
FBIOX top 10
- Krystal Biotech Inc — 10.58%
- Abbvie Inc — 9.22%
- Amgen Inc — 6.53%
- Gilead Sciences Inc — 4.82%
- Fidelity Revere Street Trust — 3.35%
- Alnylam Pharmaceuticals Inc — 2.93%
- Praxis Precision Medicines Inc. — 2.47%
- Insmed Inc — 2.25%
- Argenx Se — 2.25%
- Ascendis Pharma A/s — 2.04%
FAQ
What is the difference between FTDZX and FBIOX?
FTDZX (Franklin Biotechnology Discovery Fund) and FBIOX (Biotechnology Portfolio) are both mutual funds. FBIOX is cheaper at 0.62% vs 0.76% — a difference of $14 a year per $10,000 invested.
Which is cheaper, FTDZX or FBIOX?
FBIOX has the lower expense ratio (0.62%).
Should I own both FTDZX and FBIOX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.